Skip to Content

Achieve Life Sciences Inc ACHV

Morningstar Rating
$3.96 +0.14 (3.66%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ACHV is trading at a 40% discount.
Price
$3.97
Fair Value
$6.67
Uncertainty
Extreme
1-Star Price
$89.89
5-Star Price
$1.58
Economic Moat
Ddfdktf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ACHV is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$3.82
Day Range
$3.833.97
52-Week Range
$3.0310.30
Bid/Ask
$3.85 / $3.96
Market Cap
$83.82 Mil
Volume/Avg
23,494 / 93,693

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for nicotine addiction.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
20

Comparables

Valuation

Metric
ACHV
ICVX
HLVX
Price/Earnings (Normalized)
Price/Book Value
23.013.312.38
Price/Sales
Price/Cash Flow
Price/Earnings
ACHV
ICVX
HLVX

Financial Strength

Metric
ACHV
ICVX
HLVX
Quick Ratio
4.8917.5917.12
Current Ratio
5.3618.0617.58
Interest Coverage
−12.89−59.70
Quick Ratio
ACHV
ICVX
HLVX

Profitability

Metric
ACHV
ICVX
HLVX
Return on Assets (Normalized)
−122.68%−29.30%−30.32%
Return on Equity (Normalized)
−666.13%−31.87%−36.74%
Return on Invested Capital (Normalized)
−141.53%−34.69%−34.21%
Return on Assets
ACHV
ICVX
HLVX
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRFjjxg$550.2 Bil
VRTX
Vertex Pharmaceuticals IncJhjtq$111.1 Bil
REGN
Regeneron Pharmaceuticals IncLhvqby$107.7 Bil
MRNA
Moderna IncQkrq$36.9 Bil
ARGX
argenx SE ADRWtn$24.2 Bil
BNTX
BioNTech SE ADRHvyx$22.3 Bil
ALNY
Alnylam Pharmaceuticals IncQhqjjc$19.9 Bil
BMRN
Biomarin Pharmaceutical IncNmsfbb$17.2 Bil
RPRX
Royalty Pharma PLC Class AHmgwyb$13.9 Bil
INCY
Incyte CorpXcrqv$13.6 Bil

Sponsor Center